Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening.
about
Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.Detection of highly prevalent hepatitis B virus co-infection with HIV in Indonesia.Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia.Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.The health of female prisoners in Indonesia.Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of diseaseSubstance Use and HIV Among Female Sex Workers and Female Prisoners: Risk Environments and Implications for Prevention, Treatment, and Policies.Women with HIV in Indonesia: are they bridging a concentrated epidemic to the wider community?Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited SettingsRoutine or targeted HIV screening of Indonesian prisoners.Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008.Blood-borne viral co-infections among human immunodeficiency virus-infected inmates.HIV-related knowledge and attitudes among Indonesian prison officers.Predictors of Mortality within Prison and after Release among Persons Living with HIV in Indonesia.Risk prison and hepatitis B virus infection among inmates with history of drug injection in Isfahan, Iran.
P2860
Q31054551-3426C631-16D4-4F0C-9674-6F939898FFBEQ34556226-B793105C-B125-4F2A-B35B-B941E5115002Q34748343-7518A0DD-1BC7-4052-8C20-801AFE16D836Q35557400-9238FCD3-A6FA-47B9-AEFB-F512C279F43AQ35575830-8B09FEB3-467E-49C7-BFEB-E05C228FB03DQ35794458-A88081BC-D869-428E-81AB-79A11EF2A4B3Q35825560-579223F9-7618-4691-B00A-99AF21E4AB5AQ35863177-AF1A88D8-819D-4211-B289-1291A792EF38Q35866994-12203DE6-A5F3-4744-B4CF-3B579AEB7BC9Q35942752-4900F00A-0268-4E74-B9A9-F15367EFB8A7Q35942758-4FA3AA9E-3DD3-4324-B2E8-E6896060AF5BQ37587059-49E88A3A-AF35-416D-B73C-809277998ED8Q39739900-B21840C2-2FDC-4F4D-BE9D-2B4EE4F43DF2Q41251166-B7329781-3442-47CE-A9A2-112C75149274Q47159420-BCF2DCDC-B457-4B36-A928-F49FFAF3F38FQ51872926-FBFA2A9B-0186-41D4-8446-C704B4759A6E
P2860
Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human immunodeficiency virus, ...... implications of HIV screening.
@ast
Human immunodeficiency virus, ...... implications of HIV screening.
@en
type
label
Human immunodeficiency virus, ...... implications of HIV screening.
@ast
Human immunodeficiency virus, ...... implications of HIV screening.
@en
prefLabel
Human immunodeficiency virus, ...... implications of HIV screening.
@ast
Human immunodeficiency virus, ...... implications of HIV screening.
@en
P2093
P2860
P1476
Human immunodeficiency virus, ...... implications of HIV screening.
@en
P2093
Agnes K Indrati
Andre Meheus
Andre Van Der Ven
Erni J Nelwan
Herdiman T Pohan
Ilham Jaya
Nisaa Nuralam
Reinout Van Crevel
Reiva F Dwiyana
P2860
P304
P356
10.1111/J.1365-3156.2010.02655.X
P577
2010-10-18T00:00:00Z